logo-loader
LSE:NFX

Nuformix PLC

Receive alerts
Market:
LSE
Price
0.06 GBX
Day Change
-1.69%
Market Cap:
£1.67 m
52 weeks high
0.40
52 weeks low
0.06

In brief

Nuformix PLC is a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing.

The company aims to use its expertise in discovering, developing and patenting novel drug forms, with improved physical properties, to develop new products in new indications that are, importantly, differentiated from the original (by way of dosage, delivery route or presentation), thus creating new and attractive commercial opportunities.

Nuformix has a pipeline of preclinical assets with potential for significant value and early licensing opportunities.